Gender differences in health-related quality of life on admission to a maintenance treatment program

European Addiction Research

Volumn 11, Issue 2, 2005, Pages 69-75

  Giacomuzzi, S M ^a,b   Riemer, Y ^a   Ertl, M ^a   Kemmler, G ^a   Rossler H ^a   Hinterhuber, H ^a   Kurz, M ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Addiction; Gender differences; Maintenance treatment program; Quality of life

Indexed keywords

OPIATE;

ADULT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG USE; FEMALE; GERMANY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; LAW; MALE; MUSCLE TWITCH; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SAMPLE SIZE; SELF ESTEEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYMPTOM; THEORETICAL STUDY; URINALYSIS; VOMITING; WITHDRAWAL SYNDROME;

DEMOGRAPHY; FEMALE; HEALTH STATUS; HUMANS; MALE; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT ADMISSION; QUALITY OF LIFE; SEX FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 17244372675     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083035     Document Type: Article

References (65)

1. Bullinger M: Quality of life: definition, conceptualization and implications - A methodologist's view. Theor Surg 1991;6:143-148.
2. Sutherland HJ, Till JE: Quality of life assessments and levels of decision making: Differentiating objectives. Qual Life Res 1993;4:297-303.
3. Till JE: Measuring quality of life: Apparent benefits, potential concerns. Can J Oncol 1994;4:243-248.
4. Katschnig H, Freemann H, Sartorius N (eds): Quality of Life of Mental Disorders. Chichester, Wiley, 1997.
5. Fallowfield L: Quality of life: A new perspective for cancer patients. Nat Rev Cancer 2002;2:873-879.
6. Holme SA, Fleming CJ: Cosmetic camouflage advice improves quality of life. J Dermatol 2002;147:946-949.
7. Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J: Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997;92:707-716.
8. Torrens M, Domingo-Salvany A, Alonso J, Castillo C, San L: Methadone and quality of life. Lancet 1999;353:1101.
9. Vignau J, Brunelle E: Differences between general practitioner- and addiction centre-prescribed substitution therapy in France - Preliminary results. Eur Addict Res 1998;1:24-28.
10. Garg N, Yates WR, Jones R, Zhou M, Williams S: Effect of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. Am J Addict 1999;8:44-54.
11. Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M: A 12-year follow-up of a methadone medical maintenance program. Am J Addict 1999;8:293-299.
12. Bell J, Zador D: A risk - benefit analysis of methadone maintenance treatment. Drug Saf 2000;22:179-190.
13. Giacomuzzi SM, Riemer Y, Kemmler G, Ertl M, Richter R, Rössler H, Hinterhuber H: Substitutionsbehandlung und Lebensqualität: Methadon vs. retardiertes Morphinsulfat - eine Vergleichsstudie. Suchtmed 2001;3:89-95.
14. Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Rössler H, Hinterhuber H, Kurz M: Buprenoiphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment. Addiction 2003;98:693-702.
15. Toneatto A, Sobell LC, Shell MB: Gender issues in the treatment of abusers of alcohol, nicotine, and other drugs. J Subst Abuse 1992;4:209-218.
16. Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD: Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse 1999;8:1137-1165.
17. Fairbank JA, Dunteman GH, Condelli WS: Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. Am J Drug Alcohol Abuse 1993;19:465-474.
18. Carpenter KM, Hittner JB: Dimensional characteristics of the SCL-90-R: Evaluation of gender differences in dually diagnosed inpatients. J Clin Psychol 1995;51:383-390.
19. Ryan CF, White JM: Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996;91:39-45.
20. Grella CE, Joshi V, Hser YI: Programme variation in treatment outcomes among women in residential drug treatment. Eval Rev 2000;24:364-383.
21. Arfken CL, Borisova N, Klein C, di Menza S, Schuster CR: Women are less likely to be admitted to substance abuse treatment within 30 days of assessment. J Psychoactive Drugs 2002;34:33-38.
22. Callaghan RC, Cunningham JA: Gender differences in detoxification: Predictors of completion and re-admission. J Subst Abuse Treat 2002;4:399-407.
23. Reno RR, Aiken LS: Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict 1993;28:211-232.
24. Brown TG, Seraganian P, Tremblay J: Gender differences in substance abusers at treatment admission and at six-month follow-up. American Psychological Association Conference: Psychosocial and Behavioral Factors in Women's Health: Creating an Agenda for the 21st Century, Washington, May, 1994.
25. Oliver J: The social care directive: Development of a quality of life profile for use in community services for the mental ill. Social Work Social Sci Rev 1991;3:5-45.
26. Oliver J, Huxley P, Bridges K, Mohamed H (eds): Quality of Life and Mental Health Services. London, Routledge, 1996.
27. Priebe S, Gruyters T, Heinze M, Hoffmann C, Jäkel A: Subjektive Evaluationskriterien in der psychiatrischen Versorgung - Erhebungsmethoden für Forschung und Praxis. Psychiatr Prax 1995;22:140-144.
28. Oliver J, Huxley P, Priebe S, Kaiser W: Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol 1997;32:76-83.
29. Huxley P, Evans S, Burns T, Fahy T, Green J: Quality of life outcome in a randomized controlled trial of case management. Soc Psychiatry Psychiatr Epidemiol 2001;36:249-255.
30. van Nieuwenhuizen C, Schene AH, Koeter MW, Huxley P: The Lancashire Quality of Life Profile: Modification and psychometric evaluation. Soc Psychiatry Psychiatr Epidemiol 2001;36:36-44.
31. Ritsner M, Modai I, Kurs R, Kostizky H, Ponizovsky A: A comparison between the Hebrew versions of the Quality of Life Enjoyment and Satisfaction Questionnaire and the Lancashire Quality of Life Profile in severely mentally ill patients. Qual Life Newsl 2001;26:12-13.
32. Ruggeri M, Bisoffi G, Fontecedro L, Warner R: Subjective and objective dimensions of quality of life in psychiatric patients: A factor analytical approach. The South Verona Outcome Project 4. Br J Psychiatry 2001;178:268-275.
33. Bradley BP, Gossop M, Philips G, Legarda JJ: The development of an Opiate Withdrawal Scale (OWS). Br J Psychiatry 1987;82:1139-1142.
34. Liu ZM, Lu XX, Lian Z, Mu Y, Guo P, An X: Evaluation on drug dependence of buprenorphine. Acta Pharmacol Sin 2003;24:448-452.
35. Gossop M, Bradley B, Philips GT: An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addiction 1987;12:1-6.
36. Gossop M: The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990;15:487-490.
37. Bergner M: Quality of life, health status, and clinical research. Med Care 1989;27:148-156.
38. Bigelow DA, Gareau MJ, Young DJ: A quality of life interview for chronically disabled people . Psychosoc Reha J 1990;14:94-98.
39. Bigelow DA, McFarland BH, Olson M: Quality of life of community mental health program clients: Validating a measure. Community Ment Health J 1991;27:43-55.
40. Cella DF: Quality of life: Concepts and definition. J Pain Symptom Manage 1994;9:186-192.
41. Mast ME: Definition and measurement of quality of life in oncology nursing research: Review and theoretical implications. Oncol Nurs Forum 1995;22:957-964.
42. Gill TM, Feinstein AR: A critical appraisal of the quality of life measurements. JAMA 1994;272:619-626.
43. Jones PW: Measurement of quality of life in chronic obstructive lung disease. Eur Resp Rev 1991;1:445-453.
44. Green CA, Fenn DS, Moussaoui D, Kadri N, Hoffman WF: Quality of life in treated and never-treated schizophrenic patients. Acta Psychiatr Scand 2001;103:131-142.
45. Lehman AF: Quality of life issues and assessment among persons with schizophrenia; in Moscarelli M, Rupp A, Sartorius N (eds): Handbook of Mental Health Economics and Health Policy. Vol I: Schizophrenia. New York, Wiley, 1996, pp 37-48.
46. Farquhar M: Definitions of quality of life: A taxonomy. J Adv Nurs 1995;22:502-508.
47. Allison PJ, Locker D, Feine JS: Quality of life: A dynamic construct. Soc Sci Med 1997;45:221-230.
48. Diener E: Subjective well being: Three decades of progress. Psychol Bull 1999;125:276-302.
49. Donald A: What is quality of life? J Evid Med 2001;9:1-6.
50. Leplége A, Hunt S: The problem of quality of life in medicine. JAMA 1997;278:47-50.
51. Zimmer-Hofler D, Dobler-Mikola A: Swiss heroin-addicted females. Career and social adjustment. J Subst Abuse Treat 1992;9:159-170.
52. Powis B, Griffiths P, Gossop M, Strang J: The differences between male and female drug users: Community samples of heroin and cocaine users compared. Subst Use Misuse 1996;31:529-543.
53. Kail BL, Lukoff IF: The black female addict's career options: A typology and theory. Am J Drug Alcohol Abuse 1984;10:39-52.
54. Kaplan RM, Anderson JP, Wingard DL: Gender differences in health-related quality of life. Health Psychol 1991;10:86-93.
55. Longshore D, Hsieh S, Anglin MD: Ethnic and gender differences in drug users' perceived need for treatment. Int J Addict 1993;28:539-558.
56. Hser YI, Anglin MD, McGlothlin W: Sex differences in addict careers. 1. Initiation of use. Am J Drug Alcohol Abuse 1987;13:33-57.
57. Anglin MD, Hser YI, McGlothlin WH: Sex differences in addict careers. 2. Becoming addicted. Am J Drug Alcohol Abuse 1987;13:59-71.
58. Craddock SG, Rounds-Bryant JL, Flynn PM, Hubbard RL: Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993. Am J Drug Alcohol Abuse 1997;23:43-59.
59. ÖBIG: Bericht zur Drogensituation 2002. Wien, Österreichisches Bundesinstitut für Gesundheitswesen - Bundesministerium für soziale Sicherheit und Generationen, 2002.
60. Hser YI, Hoffman V, Grella CE, Longshore MD: A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001;58:503-508.
61. Wechsberg WM, Craddock GG, Hubbard RL: How are women who enter substance abuse treatment different than men? A gender comparison from the Drug Abuse Treatment Outcome Study (datos). Drug Soc 1998;13:97-115.
62. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D: Gender differences in the initiation of injection drug use among young adults. J Urban Health 2000;77:396-414.
63. Luthar SS, Cushing G, Rounsaville BJ: Gender differences among opioid abusers: Pathways to disorder and profiles of psychopathology. Drug Alcohol Depend 1996;179-189.
64. Franke GH, Jäger H, Stäcker KH, Beyer B: Between isolation and new hope: The psychosocial status of HIV-infected women. Psychother Psychosom Med Psychol 1995;310-320.
65. Darke S, Ross J, Lynskey M, Teesson M: Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence and risk factors. Drug Alcohol Depend 2004;73:1-10.